TNSN02003A1 - Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. - Google Patents
Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.Info
- Publication number
- TNSN02003A1 TNSN02003A1 TNTNSN02003A TNSN02003A TNSN02003A1 TN SN02003 A1 TNSN02003 A1 TN SN02003A1 TN TNSN02003 A TNTNSN02003 A TN TNSN02003A TN SN02003 A TNSN02003 A TN SN02003A TN SN02003 A1 TNSN02003 A1 TN SN02003A1
- Authority
- TN
- Tunisia
- Prior art keywords
- histamine
- antagonist
- combination
- composition containing
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'INVENTION PROPOSE UNE ASSOCIATION (a) D'UN ANTAGONISTE DES RECEPTEURS D'HISTAMINE H1 ET (b) D'UN ANTAGONISTE QUI EST AU MOINS 10 FOIS PLUS SELECTIF POUR LE RECEPTEUR D'HISTAMINE H4 QUE POUR LE RECEPTEUR D'HISTAMINE H3. ELLE CONCERNE EGALEMENT UNE COMPOSITION PHARMACEUTIQUE LA CONTENANT. APPLICATION : UTILISATION DE CETTE ASSOCIATION OU COMPOSITION POUR LE TRAITEMENT DE DIVERSES MALADIES, TELLES QUE LA RHINITE ALLERGIQUE OU L'ASTHME.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN02003A1 true TNSN02003A1 (fr) | 2005-12-23 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN02003A TNSN02003A1 (fr) | 2001-01-17 | 2002-01-16 | Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (fr) |
| JP (1) | JP2004517883A (fr) |
| KR (1) | KR20030069216A (fr) |
| CN (1) | CN1486178A (fr) |
| AP (1) | AP2002002401A0 (fr) |
| AR (1) | AR032101A1 (fr) |
| BG (1) | BG107834A (fr) |
| BR (1) | BR0206502A (fr) |
| CA (1) | CA2435121A1 (fr) |
| CR (1) | CR6983A (fr) |
| CZ (1) | CZ20031853A3 (fr) |
| DO (1) | DOP2002000325A (fr) |
| EA (1) | EA200300537A1 (fr) |
| EC (1) | ECSP034692A (fr) |
| EE (1) | EE200300335A (fr) |
| GB (1) | GB0101223D0 (fr) |
| GT (1) | GT200200003A (fr) |
| HU (1) | HUP0302767A2 (fr) |
| IL (1) | IL156087A0 (fr) |
| IS (1) | IS6818A (fr) |
| MA (1) | MA26980A1 (fr) |
| MX (1) | MXPA03006408A (fr) |
| NO (1) | NO20033223D0 (fr) |
| OA (1) | OA12440A (fr) |
| PA (1) | PA8537101A1 (fr) |
| PL (1) | PL362793A1 (fr) |
| SK (1) | SK8572003A3 (fr) |
| SV (1) | SV2003000849A (fr) |
| TN (1) | TNSN02003A1 (fr) |
| WO (1) | WO2002056871A2 (fr) |
| ZA (1) | ZA200304180B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| MXPA05002577A (es) * | 2002-09-06 | 2005-09-20 | Johnson & Johnson | Uso de moduladores del receptor h4 de histamina para el tratamiento de alergia y asma. |
| US20050090527A1 (en) * | 2003-01-28 | 2005-04-28 | Schering Corporation | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) * | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (fr) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés |
| HUE039713T2 (hu) | 2012-06-08 | 2019-02-28 | Sensorion | H4 receptor inhibitorok tinnitus kezelésére |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 PL PL02362793A patent/PL362793A1/xx not_active Application Discontinuation
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/hu unknown
- 2002-01-10 EE EEP200300335A patent/EE200300335A/xx unknown
- 2002-01-10 IL IL15608702A patent/IL156087A0/xx unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/zh active Pending
- 2002-01-10 EP EP02732099A patent/EP1353657A1/fr not_active Withdrawn
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/cs unknown
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/sk unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/ko not_active Application Discontinuation
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/fr not_active Application Discontinuation
- 2002-01-10 CA CA002435121A patent/CA2435121A1/fr not_active Abandoned
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/ja not_active Withdrawn
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/pt not_active IP Right Cessation
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/es unknown
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 EA EA200300537A patent/EA200300537A1/ru unknown
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/es unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/es unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/fr unknown
- 2002-01-16 GT GT200200003A patent/GT200200003A/es unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/es not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/es not_active Application Discontinuation
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/is unknown
- 2003-05-21 BG BG107834A patent/BG107834A/bg unknown
- 2003-05-22 CR CR6983A patent/CR6983A/es not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/fr unknown
- 2003-07-16 NO NO20033223A patent/NO20033223D0/no not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004517883A (ja) | 2004-06-17 |
| BR0206502A (pt) | 2003-10-21 |
| HUP0302767A2 (hu) | 2003-11-28 |
| ECSP034692A (es) | 2003-08-29 |
| CR6983A (es) | 2003-11-25 |
| GB0101223D0 (en) | 2001-02-28 |
| EP1353657A1 (fr) | 2003-10-22 |
| MXPA03006408A (es) | 2003-10-15 |
| CZ20031853A3 (cs) | 2004-07-14 |
| KR20030069216A (ko) | 2003-08-25 |
| IS6818A (is) | 2003-05-15 |
| ZA200304180B (en) | 2004-06-15 |
| WO2002056871A2 (fr) | 2002-07-25 |
| BG107834A (bg) | 2004-01-30 |
| SK8572003A3 (en) | 2004-07-07 |
| PL362793A1 (en) | 2004-11-02 |
| IL156087A0 (en) | 2003-12-23 |
| AR032101A1 (es) | 2003-10-22 |
| EE200300335A (et) | 2003-12-15 |
| PA8537101A1 (es) | 2002-08-29 |
| SV2003000849A (es) | 2003-01-13 |
| MA26980A1 (fr) | 2004-12-20 |
| CN1486178A (zh) | 2004-03-31 |
| OA12440A (en) | 2006-05-22 |
| EA200300537A1 (ru) | 2004-02-26 |
| NO20033223L (no) | 2003-07-16 |
| DOP2002000325A (es) | 2003-01-31 |
| GT200200003A (es) | 2002-08-19 |
| CA2435121A1 (fr) | 2002-07-25 |
| AP2002002401A0 (en) | 2002-03-31 |
| NO20033223D0 (no) | 2003-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN01068A1 (fr) | Compositions pharmaceutiques pour le traitement de maladies comportant un dysfonctionnement cognitif | |
| TNSN01053A1 (fr) | Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique | |
| DE69531998D1 (de) | Steroidrezeptor-modulator verbindungen und methoden | |
| ATE300533T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
| TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| DE60103556D1 (de) | Zusammensetzungen zur behandlung von fettleibigkeit, welche antagonisten der cb1-rezeptoren und sibutramine enthalten | |
| TNSN01040A1 (fr) | Compositions nouvelles comprenant des inhibiteurs de glycogene- phosphorylase | |
| TNSN00183A1 (fr) | COMPOSITIONS COMPRENANT LE POLYPEPTIDE IL-1ra ET UN INHIBITEUR DE MATURATION ET DE LIBERATION DE IL-1 ET METHODES DE TRAITEMENT LES UTILISANT | |
| MA31016B1 (fr) | Composes de diazepan substitues comme antagonistes des recepteurs de l'orexine. | |
| TNSN01173A1 (fr) | Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda. | |
| BR0007147A (pt) | Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação | |
| HUP0301729A2 (hu) | Gyógyszer szívelégtelenség megelżzésére és kezelésére | |
| DE60210904D1 (de) | Nitrit-stabilisierte Zusammensetzungen von Tetrazolium-Reagenz und Methoden derer Nutzung | |
| BR9813957A (pt) | Uso de antagonistas da vasopressina | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| TNSN98227A1 (fr) | Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant. | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| MA27101A1 (fr) | Composition pharmaceutique orodispersible d'agomelatine | |
| EP1633733A4 (fr) | Derives cannabinoides, leurs methodes de fabrication et leurs applications | |
| TNSN02003A1 (fr) | Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. | |
| DE69906944T2 (de) | 20-hete antagonisten und agonisten | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| ATE348812T1 (de) | Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf) | |
| ATE266420T1 (de) | Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält | |
| BR0015980A (pt) | Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii |